Comparative analysis of bevacizumab and LITT for treating radiation necrosis in previously radiated CNS neoplasms: a systematic review and meta-analysis.

Neslihan Nisa GeciciMuhammet Enes GursesBrandon KayeNatasha L Frontera JimenezChandler BerkeElif GökalpVictor M LuMichael E IvanRicardo J KomotarAshish H Shah

Published in: Journal of neuro-oncology (2024)

Both bevacizumab and LITT exhibited favorable clinical and radiological outcomes in managing RN. Bevacizumab was found to be associated with better symptomatic control compared to LITT. Patient-, diagnosis- and lesion-related factors should be considered when choosing the ideal treatment modality for RN to enhance overall patient outcomes.

Keyphrases

metastatic colorectal cancer
case report
blood brain barrier
type diabetes
radiation induced
skeletal muscle
insulin resistance
weight loss